Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Current Investments (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Cash & Current Investments data on record, last reported at $94.3 million in Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 30.72% year-over-year to $94.3 million; the TTM value through Dec 2025 reached $94.3 million, down 30.72%, while the annual FY2025 figure was $94.3 million, 30.72% down from the prior year.
  • Cash & Current Investments reached $94.3 million in Q4 2025 per ORGO's latest filing, up from $64.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $136.2 million in Q4 2024 and bottomed at $487000.0 in Q3 2021.
  • Average Cash & Current Investments over 5 years is $84.2 million, with a median of $94.6 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 22080.9% in 2022, then tumbled 32.19% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $114.5 million in 2021, then fell by 9.81% to $103.3 million in 2022, then rose by 1.01% to $104.3 million in 2023, then skyrocketed by 30.49% to $136.2 million in 2024, then plummeted by 30.72% to $94.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $94.3 million in Q4 2025, $64.4 million in Q3 2025, and $73.7 million in Q2 2025.